Influenza vaccination for older adults

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 1, 2012, Pages 96-101

  Talbot, H Keipp B ^a   Libster, Romina ^a,b   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Ciudad Autónoma de Buenos Aires   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AS 03; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MIFAMURTIDE; PLACEBO; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; ADJUVANT;

ADJUVANT THERAPY; AGED; ANTIBODY TITER; COMMUNITY LIVING; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FRAIL ELDERLY; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK REDUCTION; SEASONAL INFLUENZA; SENESCENCE; SEROCONVERSION; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; ADULT; CELLULAR IMMUNITY; FLU LIKE SYNDROME; IMMUNOCOMPETENCE; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; OUTCOME ASSESSMENT; VACCINATION REACTION;

EID: 84861812768     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.8.1.18129     Document Type: Review

References (45)

1. Langmuir AD, Henderson DA, Serfling RE. The Epidemiological Basis for the Control of Influenza. Am J Public Health Nations Health 1964; 54:563-71; PMID:14136320; http://dx.doi.org/10.2105/AJPH. 54.4.563
2. Francis T, Magill TP. The Antibody Response of Human Subjects Vaccinated with the Virus of Human Influenza. J Exp Med 1937; 65:251-9; PMID: 19870599; http://dx.doi.org/10.1084/jem.65.2.251
3. Beyer WE, Palache AM, Osterhaus AD. Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature. Clin Drug Investig 1998; 15:1-12; PMID:18370460; http://dx.doi.org/10. 2165/00044011-199815010-00001
4. Francis T, Jr., Getting VA, et al. The present status of vaccination against influenza. Am J Public Health Nations Health 1947; 37:1109-12; http://dx.doi.org/ 10.2105/AJPH.37.9.1109
5. Cate TR. Clinical manifestations and consequences of influenza. Am J Med 1987; 82:15-9; PMID: 3591813; http://dx.doi.org/10.1016/0002-9343(87) 90555-9
6. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA 2005; 293:987-97; PMID:15728170; http://dx. doi.org/10.1001/jama.293.8.987
7. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000; 31:1166-9; PMID:11073747; http://dx.doi.org/10.1086/317425
8. Govaert TM, Dinant GJ, Aretz K, Knottnerus JA. The predictive value of influenza symptomatology in elderly people. Fam Pract 1998; 15:16-22; PMID:9527293; http://dx.doi.org/10.1093/fampra/15.1.16
9. Matsuno O, Kataoka H, Takenaka R, Okubo F, Okamoto K, Masutomo K, et al. Influence of age on symptoms and laboratory findings at presentation in patients with influenza-associated pneumonia. Arch Gerontol Geriatr 2009; 49:322-5; PMID:19150140; http://dx.doi.org/10.1016/j.archger.2008.11.015
10. Neuzil KM, O'Connor TZ, Gorse GJ, Nichol KL. Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clin Infect Dis 2003; 36:169-74; PMID:12522748; http://dx.doi.org/10.1086/345668
11. Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2006; 27:266-70; PMID:16532414; http://dx.doi.org/ 10.1086/501539
12. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc 2002; 50:1498-503; PMID:12383146; http://dx.doi.org/10.1046/j.1532-5415.2002.50404.x
13. Flamaing J, Engelmann I, Joosten E, Van Ranst M, Verhaegen J, Peetermans WE. Viral lower respiratory tract infection in the elderly: a prospective in-hospital study. Eur J Clin Microbiol Infect Dis 2003; 22:720-5; PMID:14605944; http://dx.doi.org/10.1007/s10096- 003-1042-z
14. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749-59; PMID:15858184; http://dx.doi.org/10. 1056/NEJMoa043951
15. Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, et al. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine 2008; 26:4057-61; PMID:18602726; http:// dx.doi.org/10.1016/j. vaccine.2008.05.024
16. Praditsuwan R, Assantachai P, Wasi C, Puthavatana P, Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 2005; 88:256-64; PMID:15962680
17. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized doubleblind placebo-controlled trial. JAMA 1994; 272:1661-5; PMID:7966893; http://dx.doi.org/10.1001/jama.272.21. 1661
18. Allsup S, Haycox A, Regan M, Gosney M. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine 2004; 23:639-45; PMID:15542184
19. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews. 2010.
20. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006; 3:CD004876; PMID:16856068
21. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and costbenefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000; 284:1655-63; PMID:11015795; http://dx.doi.org/10. 1001/jama.284.13.1655
22. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31; PMID:17403908; http://dx.doi.org/ 10.1093/ije/dym021
23. Talbot HK, Williams JV, Zhu Y, Poehling KA, Griffin MR, Edwards KM. Failure of routine diagnostic methods to detect influenza in hospitalized older adults. Infect Control Hosp Epidemiol 2010; 31:683-8; PMID:20470035; http://dx.doi.org/10.1086/653202
24. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011; 203:500-8; PMID:21220776; http://dx.doi.org/ 10.1093/infdis/jiq076
25. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173:489-95; PMID:16129869; http://dx.doi.org/10. 1503/cmaj.050051
26. Strandberg TE, Pitkala KH. Frailty in elderly people. Lancet 2007; 369:1328-9; PMID:17448804; http://dx. doi.org/10.1016/S0140-6736(07)60613-8
27. Yao X, Hamilton RG, Weng NP, Xue QL, Bream JH, Li H, et al. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in communitydwelling older adults. Vaccine 2011; 29:5015-21; PMID:21565245; http://dx.doi.org/10.1016/j.vaccine. 2011.04.077
28. Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009; 27:1628-36; PMID:19100304; http://dx.doi.org/10. 1016/j.vaccine.2008.11. 098
29. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35:337-44; PMID:16368725; http://dx.doi.org/10. 1093/ije/dyi274
30. Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006; 35:345-52; PMID:16368724; http://dx.doi.org/10.1093/ije/dyi275
31. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010; 28:7267-72; PMID:20832494; http://dx.doi.org/10.1016/j.vaccine.2010.08.088
32. Greene SK, Shi P, Dutta-Linn MM, Shoup JA, Hinrichsen VL, Ray P, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med 2009; 37:552-5; PMID:19944924; http://dx.doi.org/10.1016/ j.amepre. 2009.08.022
33. Place of influenza vaccination among adults-United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep 2011; 60:781-5; PMID:21681175
34. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of Immune Responses to Vaccines in Elderly Persons. Clin Infect Dis 2008; 46:1078-84; PMID:18444828; http://dx.doi.org/10. 1086/529197
35. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; PMID:16213065; http://dx.doi.org/10.1016/j.vaccine.2005.08.105
36. Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011; 121:3109-19; PMID:21785218; http://dx.doi.org/10.1172/JCI57834
37. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172-80; PMID: 19508159; http://dx.doi.org/10.1086/599790
38. Rappuoli R, Del Giudice G, Nabel GJ, Osterhaus AD, Robinson R, Salisbury D, et al. Public health. Rethinking influenza. Science 2009; 326:50; PMID:19797644; http://dx.doi.org/10.1126/science.1179475
39. Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine 2009; 27:6959-65; PMID:19751689; http://dx.doi.org/10.1016/j.vaccine.2009.08.101
40. Cheong HJ, Song JY, Heo JY, Noh JY, Choi WS, Park DW, et al. Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine. Clin Vaccine Immunol 2011; 18:1358-64; PMID:21715575; http://dx.doi. org/10.1128/CVI.05111-11
41. Carmona A, Omeñaca F, Tejedor JC, Merino JM, Vaman T, Dieussaert I, et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine 2010; 28: 5837-44; PMID:20600478; http://dx.doi.org/10.1016/ j.vaccine.2010.06.065
42. Langley JM, Frenette L, Ferguson L, Riff D, Sheldon E, Risi G, et al. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. J Infect Dis 2010; 201:1644-53; PMID:20423222; http://dx.doi.org/10. 1086/652701
43. Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, et al. Priming with AS03Aadjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study. Vaccine 2010; 28:849-57; PMID:19835828; http://dx.doi.org/10.1016/j.vaccine. 2009.10.017
44. Rubinstein E, Predy G, Sauvé L, Hammond GW, Aoki F, Sikora C, et al. The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine. CMAJ 2011; 183:E1033-7; PMID:21788422; http://dx. doi.org/10.1503/cmaj.110196
45. Heijmans S, De Meulemeester M, Reynders P, Giet D, Demanet E, Devresse PY, et al. Immunogenicity profile of a 3.75-mug hemagglutinin pandemic rH5N1 split virion AS03A-adjuvanted vaccine in elderly persons: a randomized trial. J Infect Dis 2011; 203:1054-62; PMID: 21450995; http://dx.doi.org/10.1093/infdis/ jiq174